Skip to main content

Jose de Ribamar Costa, Jr., MD, PhD

Cardiovascular Risk Stratification for Patients Treated With Drug-Eluting Stents: Development and Validation of the DESIRE Score
Original Contribution
03/01/2020
We developed a risk score to estimate the risk of major adverse cardiac event (MACE) during the in-hospital and long-term follow-up periods after PCI with drug-eluting stent (DES) implantation.
We developed a risk score to estimate the risk of major adverse cardiac event (MACE) during the in-hospital and long-term follow-up periods after PCI with drug-eluting stent (DES) implantation.
We developed a risk score to...
03/01/2020
Journal of Invasive Cardiology
08/01/2008
In-stent restenosis is the result of neointimal hyperplasia that, by intravascular ultrasound (IVUS) imaging, typically has a homogeneous, echoreflective appearance. Histological and immunohistochemical analyses of “typical” in-stent...
In-stent restenosis is the result of neointimal hyperplasia that, by intravascular ultrasound (IVUS) imaging, typically has a homogeneous, echoreflective appearance. Histological and immunohistochemical analyses of “typical” in-stent...
In-stent restenosis is the...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Despite the recent advent of drug-eluting stents (DES), preparation of complex lesions (e.g., ostial, diffuse, fibrocalcified lesions and in-stent restenosis) before stent implantation remains an essential component of percutaneous coronary...
Despite the recent advent of drug-eluting stents (DES), preparation of complex lesions (e.g., ostial, diffuse, fibrocalcified lesions and in-stent restenosis) before stent implantation remains an essential component of percutaneous coronary...
Despite the recent advent of...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...
Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...
Sirolimus-eluting and...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Although stenting has improved clinical outcomes of patients undergoing percutaneous coronary intervention (PCI), bare-metal stents are associated with a considerable risk of restenosis.1,2 The main cause of in-stent restenosis is excessive...
Although stenting has improved clinical outcomes of patients undergoing percutaneous coronary intervention (PCI), bare-metal stents are associated with a considerable risk of restenosis.1,2 The main cause of in-stent restenosis is excessive...
Although stenting has improved...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
09/10/2008
ABSTRACT: Background. Despite the increasing number of elderly people, this high-complexity subset of patients is often excluded from randomized trials of percutaneous coronary intervention (PCI) and, therefore, limited data are available...
ABSTRACT: Background. Despite the increasing number of elderly people, this high-complexity subset of patients is often excluded from randomized trials of percutaneous coronary intervention (PCI) and, therefore, limited data are available...
ABSTRACT: Background. Despite...
09/10/2008
Journal of Invasive Cardiology
Original Contribution
08/25/2015
The use of the Svelte Acrobat Integrated Delivery System via radial approach with 5 Fr catheters is evaluated for safety and efficacy. In this 50-patient study, the authors show that this direct stenting system enables easy delivery,...
The use of the Svelte Acrobat Integrated Delivery System via radial approach with 5 Fr catheters is evaluated for safety and efficacy. In this 50-patient study, the authors show that this direct stenting system enables easy delivery,...
The use of the Svelte Acrobat...
08/25/2015
Journal of Invasive Cardiology
Original Contribution
05/31/2017
The present study examined the association between Multicenter CTO Registry in Japan (J-CTO) score in predicting failure of percutaneous coronary intervention correlating with the estimated duration of chronic total occlusion.
The present study examined the association between Multicenter CTO Registry in Japan (J-CTO) score in predicting failure of percutaneous coronary intervention correlating with the estimated duration of chronic total occlusion.
The present study examined the...
05/31/2017
Journal of Invasive Cardiology
Original Contribution
06/15/2017
We sought to assess the outcomes of patients treated with second-generation drug-eluting stent classified according to the updated American College of Cardiology Foundation/American Heart Association/Society for Cardiac Angiography and...
We sought to assess the outcomes of patients treated with second-generation drug-eluting stent classified according to the updated American College of Cardiology Foundation/American Heart Association/Society for Cardiac Angiography and...
We sought to assess the outcomes...
06/15/2017
Journal of Invasive Cardiology
Original Contribution
12/14/2023
In the present study, the authors sought to investigate the role of sevoflurane in reduction of creatine kinase-myocardial band mass release after percutaneous coronary intervention with drug-eluting stents.
In the present study, the authors sought to investigate the role of sevoflurane in reduction of creatine kinase-myocardial band mass release after percutaneous coronary intervention with drug-eluting stents.
In the present study, the...
12/14/2023
Journal of Invasive Cardiology